The therapeutic potential of the ketogenic diet (KD) for breast cancer (BC).
Optum’s biosimilar business to exclude brand-name Stelara, Humira in 2025
Optum Rx is moving into the biosimilar business with a company it’s calling Nuvaila, and it’s starting out with biosimilars to AbbVie’s blockbuster rheumatoid arthritis